NINGBO MENOVO PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.77 CNY | +0.47% |
|
+5.02% | -33.21% |
| Apr. 23 | Menovo Pharmaceutical Unit Gets Approval to Register Vildagliptin Tablets | MT |
| Apr. 16 | Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on July 20, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Ningbo Menovo Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of special active pharmaceutical ingredients (APIs) and medical intermediates. The Companyâs products contain gastropathic medicine and cardiovascular medicine, which include anti-hypertension medicine, anti-hyperlipidemia medicine and anti-thrombus medicine. The Company distributes its products to both domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.77
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.21% | 376M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 603538 Stock
- News Ningbo Menovo Pharmaceutical Co., Ltd.
- Menovo Pharma Gets Nod to Market Raw Drug Ingredient for Hypertension Into EU Market; Shares Up 3%
